European Biotech Acquisit...

NASDAQ: EBACU · Real-Time Price · USD
11.30
0.40 (3.67%)
At close: Mar 02, 2023, 9:53 PM

European Biotech Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-2.82M -1.1M
Interest Income
n/a n/a
Pretax Income
342.89K 1.48M
Net Income
3.5M 1.48M
Selling & General & Admin
2.79M 1.1M
Research & Development
n/a n/a
Other Expenses
32.94K n/a
Operating Expenses
2.82M 1.1M
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
2.82M 1.1M
Income Tax Expense
-3.16M n/a
Shares Outstanding (Basic)
12.76M 3.41M
Shares Outstanding (Diluted)
12.76M 13.66M
EPS (Basic)
0.27 0.43
EPS (Diluted)
0.27 0.11
EBITDA
-2.82M -3.68M
EBIT
n/a -1.1M
Depreciation & Amortization
-3.16M -2.58M